Every fall, the lung cancer community gathers to raise awareness for this disease and stand together – unified and strong.

November is Lung Cancer Awareness Month – a time to come together to celebrate the strength of the lung cancer community.

Whether you are newly diagnosed or a long-term survivor, LUNGevity offers lung cancer support and survivorship services to address your unique needs. LUNGevity's services are designed to help you feel supported, informed, and empowered to be an active decision-maker in your treatment process and live well with the disease. 

For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000 people in the US are diagnosed with lung cancer. The high incidence of lung cancer means scientific research into new therapies is critical, both for current survivors and those who will be diagnosed in the future. Thankfully, the landscape of lung cancer is changing for the better.

Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, chats with Jill Feldman and Ivy Elkins, co-founders of the EGFR Resisters; and Drs. Christine Lovly, MD, PhD (Vanderbilt University) and Helena Yu, MD (Memorial Sloan Kettering), who received the 2021 EGFR Resisters/LUNGevity Foundation Awards. Hear first-hand from both patients and researchers about why this patient-driven partnership matters to the EGFR community.

Sleep tips session with our sleep expert, Peggy Burhenn.